Unfortunately, no. They provide no sales targets, revenue targets, expense targets, etc. I find this very strange to have essentially zero performance targets in place - even if you look at their own KPIs as director's it's on things like FDA approval and the stock price. I would really hope that this changes in the next report once they have more knowledge of the business and confidence in predicting the distribution channels.
Ann: Change of Director's Interest Notice, page-34
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
-0.005(1.14%) |
Mkt cap ! $49.00M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 43.3¢ | $26.28K | 59.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24427 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 4000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |